Chronic paranoid psychosis and dementia following interferon-α treatment of hepatitis C: A case report

Pharmacopsychiatry

Volumn 40, Issue 4, 2007, Pages 146-148

  Drozdz, W ^a   Borkowska, A ^a   Wilkosc, M ^a   Halota, W ^a   Dybowska, D ^a   Rybakowski, J K ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AMISULPRIDE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PERAZINE; QUETIAPINE; RIBAVIRIN; SULPIRIDE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER TOXICITY; LOW DRUG DOSE; MALE; PARANOID PSYCHOSIS; PRIORITY JOURNAL; RISK FACTOR; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; CHRONIC DISEASE; DEMENTIA; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; NEUROPSYCHOLOGICAL TESTS; PARANOID DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 34548721488     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-984390     Document Type: Article

References (21)

1. Bozikas V, Petrikis P, Balla A, Karavatos A. An interferon-alpha-induced psychotic disorder in a patient with chronic hepatitis C. Eur Psychiatry 2001; 16: 136-137
2. Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 2007, in press (doi: 10.1038/sj.npp.1301362)
3. Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D. Alpha-interferon and mental disorders. Encephale 2001; 27: 308-317
4. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157: 867-876
5. D'Innella P, Zaccala G, Terazzi M, Olgiati P, Torre E. Psychotic disorders induced by interferon alfa. Recenti Prog Med 2002; 93: 367-369
6. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47
7. Garcia-Pares G, Domenech C, Gil M. Psychosis induced by interferon-alpha. Psychosomatics 2002; 43: 428-429
8. Heiden U an der. Schizophrenia as a dynamical disease. Pharmacopsychiatry 2006; 39 (Suppl 1): 36-42
9. Hosoda S, Takimura H, Shibayama M, Kanamura H, Ikeda K, Kumada H. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurose 2000; 54: 565-572
10. Howes O, MacKenzie KJ. Manic psychosis induced by long term alpha-interferon treatment for hepatitis C. Int J Psychiatry Clin Pract 2000; 4: 161-162
11. Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU et al. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 2000; 152: 383-389
12. Kalyoncu OA, Tan D, Mirsal H, Pektas O, Beyazyurek M. Major depressive disorder with psychotic features induced by interferon-α treatment for hepatitis C in a polydrug abuser. J Psychopharmacol 2005; 19: 102-105
13. Kamei S, Sakai T, Matsuura M, Tanaka N, Kojima T, Arakawa Y et al. Alterations of quantitative EEG and mini-mental state examination in interferon-alpha-treated hepatitis C. Eur Neurol 2002; 48: 102-107
14. Kamei S, Tanaka N, Mastuura M, Arakawa Y, Kojima T, Matsukawa Y et al. Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C. Acta Neurol Scand 1999; 100: 25-33
15. Kornischka J, Burtscheidt W, Gaebel W. Interferon-induced paranoid psychosis Review of the literature and case report. Nervenarzt 2002; 73: 463-467
16. Leuner K, Muller WE. The complexity of the dopaminergic synapses and their modulation by antipsychotics. Pharmacopsychiatry 2006; 39 (Suppl 1): S15-20
17. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991; 41: 672-676
18. Mungas D, Marshall SC, Weldon M, Haan M, Reed BR. Age and education correction of Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology 1996; 46: 700-706
19. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin Neurosci 1997; 51: 175-180
20. Spreen O, Strauss E (editors). A compendium of neuropsychological tests. Administration, norms and commentary. New York, Oxford, Oxford University Press, 1998
21. Uttl B, Graf P. Color-Word Stroop test performance across the adult life span. J Clin Exp Neuropsychol 1997; 19: 405-420